1 – 10 of 4738
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Genetic variants of filaggrin are associated with occupational dermal exposure and blood DNA alterations in hairdressers
- All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
- Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations
- 2018
- Molecular subtype profiling of urothelial carcinoma using a subtype-specific immunohistochemistry panel
- Burden of cancer in the Eastern Mediterranean Region, 2005-2015 : findings from the Global Burden of Disease 2015 Study
- Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
- The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant : Breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
- Response "Unresectable Colorectal Liver Metastases: : When Definitions Matter to Appropriately Assess Extreme Liver Resection Techniques"
- Haem iron intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
- Blood levels of cadmium and lead in relation to breast cancer risk in three prospective cohorts